We found changes in the antioxidant profile in IBD patients unresponsive to pharmacological treatment when compared with controls: SOD activity, and total GSH and GSSG levels were decreased in both CD and UC patients, whereas GPX activity significantly decreased only in case of CD vs. controls. Here, SOD1 is linked to irritable bowel syndrome.